Recurrent Melanoma Recruiting Phase 0 Trials for Propranolol (DB00571)

Also known as: Melanoma Recurrent

IndicationStatusPhase
DBCOND0028662 (Recurrent Melanoma)Recruiting0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02013492Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By SurgeryTreatment